Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Venous Thromboembolism 11Neoplasms 9Pulmonary Embolism 6Venous Thrombosis 5Thrombosis 3Neoplasm Metastasis 2Myeloproliferative Disorders 2Intracranial Thrombosis 2Thrombocythemia, Essential 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Pancreatic Neoplasms 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Mesenteric Ischemia 1Lymphoma 1Hematologic Neoplasms 1

Interventions

Cyclophosphamide 32Tacrolimus 29fludarabine 27Mycophenolic Acid 23fludarabine phosphate 22Busulfan 19Whole-Body Irradiation 18Melphalan 16Methotrexate 15Antilymphocyte Serum 14Rituximab 12Bortezomib 11Stem Cell Transplantation 10Cyclosporine 10thymoglobulin 9Sirolimus 9Granulocyte Colony-Stimulating Factor 9Peripheral Blood Stem Cell Transplantation 8Thiotepa 7Interviews as Topic 7Filgrastim 7Dexamethasone 7Clofarabine 7Blood Specimen Collection 6Alemtuzumab 6merphos 5Voriconazole 5Standard of Care 5Nivolumab 5Lenalidomide 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hematologic Neoplasms × apixaban × Clear all
NCT03080883 2025-05-18

Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

Academic and Community Cancer Research United

Phase 3 Completed
370 enrolled 16 charts
Other hematologic neoplasm

Neoplasm Metastasis, Pulmonary Embolism, Hematologic Neoplasms, Venous Thrombosis, Intracranial Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡